MPT

SEC source: 0001193125-25-233764 · ownership.xml · nonDerivative · entry 1

Portal Larry H · CIK 0001969950 · SVP, Senior Advisor to the CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 481,691

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0001193125-25-233762 · ownership.xml · nonDerivative · entry 1

Hooper Rosa Handley · CIK 0001969905 · SVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 397,182

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0001193125-25-233760 · ownership.xml · nonDerivative · entry 1

LAMBERT CHARLES R · CIK 0001225492 · SVP of Finance and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 320,237

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0001193125-25-220827 · ownership.xml · nonDerivative · entry 2

Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 449,231

F2 · shares: The shares were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period ending April 14, 2028 as follows: (i) if the Company's TSR reaches 20%, 100% of the shares will be earned; (ii) if the Company's TSR reaches 40%, 200% of the shares will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the shares will be earned. The actual number of shares to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 3).

F3 · shares: Earned shares will become vested in equal quarterly installments over one year following the date the shares are earned, provided that all unvested earned shares will vest in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.

SEC source: 0001193125-25-220827 · ownership.xml · nonDerivative · entry 1

Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 424,173

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2028.

SEC source: 0001193125-25-220833 · ownership.xml · nonDerivative · entry 2

Hooper Rosa Handley · CIK 0001969905 · SVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,743

F2 · shares: The shares were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period ending April 14, 2028 as follows: (i) if the Company's TSR reaches 20%, 100% of the shares will be earned; (ii) if the Company's TSR reaches 40%, 200% of the shares will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the shares will be earned. The actual number of shares to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 3).

F3 · shares: Earned shares will become vested in equal quarterly installments over one year following the date the shares are earned, provided that all unvested earned shares will vest in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.

SEC source: 0001193125-25-220833 · ownership.xml · nonDerivative · entry 1

Hooper Rosa Handley · CIK 0001969905 · SVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 385,323

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2028.

SEC source: 0001193125-25-220831 · ownership.xml · nonDerivative · entry 2

LAMBERT CHARLES R · CIK 0001225492 · SVP of Finance and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 323,865

F2 · shares: The shares were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period ending April 14, 2028 as follows: (i) if the Company's TSR reaches 20%, 100% of the shares will be earned; (ii) if the Company's TSR reaches 40%, 200% of the shares will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the shares will be earned. The actual number of shares to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 3).

F3 · shares: Earned shares will become vested in equal quarterly installments over one year following the date the shares are earned, provided that all unvested earned shares will vest in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.

SEC source: 0001193125-25-220831 · ownership.xml · nonDerivative · entry 1

LAMBERT CHARLES R · CIK 0001225492 · SVP of Finance and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 304,590

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2028.

SEC source: 0001193125-25-220829 · ownership.xml · nonDerivative · entry 2

Portal Larry H · CIK 0001969950 · SVP, Senior Advisor to the CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 488,647

F2 · shares: The shares were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period ending April 14, 2028 as follows: (i) if the Company's TSR reaches 20%, 100% of the shares will be earned; (ii) if the Company's TSR reaches 40%, 200% of the shares will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the shares will be earned. The actual number of shares to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 3).

F3 · shares: Earned shares will become vested in equal quarterly installments over one year following the date the shares are earned, provided that all unvested earned shares will vest in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.

SEC source: 0001193125-25-220829 · ownership.xml · nonDerivative · entry 1

Portal Larry H · CIK 0001969950 · SVP, Senior Advisor to the CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 463,589

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2028.

SEC source: 0000950170-25-094664 · ownership.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,985,518

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-094665 · ownership.xml · nonDerivative · entry 1

Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 364,430

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-094668 · ownership.xml · nonDerivative · entry 1

LAMBERT CHARLES R · CIK 0001225492 · SVP of Finance and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 258,634

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-094667 · ownership.xml · nonDerivative · entry 1

Portal Larry H · CIK 0001969950 · SVP, Senior Advisor to the CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 403,846

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-094666 · ownership.xml · nonDerivative · entry 1

Hooper Rosa Handley · CIK 0001969905 · SVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 348,558

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-094663 · ownership.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,354,656

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-063782 · ownership.xml · nonDerivative · entry 1

Stewart Michael G · CIK 0001331453 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,100

F1 · price: This transaction was executed in multiple trades at prices ranging from $5.20 to $5.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000950170-25-055631 · ownership.xml · derivative · entry 3

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,107,020

Underlying: Common stock, par value $0.001 · 207,020 shares

Expires not disclosed

F4 · shares: The restricted stock units were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period beginning April 15, 2025 (the "Grant Date") as follows: (i) if the Company's TSR reaches 20%, 100% of the restricted stock units will be earned; (ii) if the Company's TSR reaches 40%, 200% of the restricted stock units will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 5).

F5 · shares: Earned restricted stock units will be settled in cash (based on the average price of the Company's common stock over the five trading days ending on the applicable vesting date) in equal quarterly installments over one year following the date the restricted stock units are earned, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.

F4 · derivative.exercise_date: The restricted stock units were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period beginning April 15, 2025 (the "Grant Date") as follows: (i) if the Company's TSR reaches 20%, 100% of the restricted stock units will be earned; (ii) if the Company's TSR reaches 40%, 200% of the restricted stock units will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 5).

F5 · derivative.exercise_date: Earned restricted stock units will be settled in cash (based on the average price of the Company's common stock over the five trading days ending on the applicable vesting date) in equal quarterly installments over one year following the date the restricted stock units are earned, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.

F4 · derivative.expiration_date: The restricted stock units were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period beginning April 15, 2025 (the "Grant Date") as follows: (i) if the Company's TSR reaches 20%, 100% of the restricted stock units will be earned; (ii) if the Company's TSR reaches 40%, 200% of the restricted stock units will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 5).

F5 · derivative.expiration_date: Earned restricted stock units will be settled in cash (based on the average price of the Company's common stock over the five trading days ending on the applicable vesting date) in equal quarterly installments over one year following the date the restricted stock units are earned, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.

SEC source: 0000950170-25-055631 · ownership.xml · nonDerivative · entry 2

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,023,989

F3 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2028.

SEC source: 0000950170-25-055631 · ownership.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,529,963

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

F2 · balance_after: The total amount of securities beneficially owned following the reported transaction includes a decrease of 117,282 shares as a result of forfeitures related to previously disclosed share awards.

SEC source: 0000950170-25-055632 · ownership.xml · nonDerivative · entry 1

Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365,709

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

F2 · balance_after: The total amount of securities beneficially owned following the reported transaction includes a decrease of 4,945 shares as a result of forfeitures related to previously disclosed share awards.

SEC source: 0000950170-25-055635 · ownership.xml · nonDerivative · entry 1

Hooper Rosa Handley · CIK 0001969905 · SVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349,421

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

F2 · balance_after: The total amount of securities beneficially owned following the reported transaction includes a decrease of 4,496 shares as a result of forfeitures related to previously disclosed share awards.

SEC source: 0000950170-25-055634 · ownership.xml · nonDerivative · entry 1

Portal Larry H · CIK 0001969950 · SVP, Senior Advisor to the CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 405,417

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

F2 · balance_after: The total amount of securities beneficially owned following the reported transaction includes a decrease of 5,994 shares as a result of forfeitures related to previously disclosed share awards.

SEC source: 0000950170-25-055633 · ownership.xml · nonDerivative · entry 1

LAMBERT CHARLES R · CIK 0001225492 · SVP of Finance and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 258,889

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

F2 · balance_after: The total amount of securities beneficially owned following the reported transaction includes a decrease of 2,497 shares as a result of forfeitures related to previously disclosed share awards.

SEC source: 0000950170-25-055630 · ownership.xml · derivative · entry 3

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,214,041

Underlying: Common stock, par value $0.001 · 414,041 shares

Expires not disclosed

F4 · shares: The restricted stock units were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period beginning April 15, 2025 (the "Grant Date") as follows: (i) if the Company's TSR reaches 20%, 100% of the restricted stock units will be earned; (ii) if the Company's TSR reaches 40%, 200% of the restricted stock units will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 5).

F5 · shares: Earned restricted stock units will be settled in cash (based on the average price of the Company's common stock over the five trading days ending on the applicable vesting date) in equal quarterly installments over one year following the date the restricted stock units are earned, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.

F4 · derivative.exercise_date: The restricted stock units were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period beginning April 15, 2025 (the "Grant Date") as follows: (i) if the Company's TSR reaches 20%, 100% of the restricted stock units will be earned; (ii) if the Company's TSR reaches 40%, 200% of the restricted stock units will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 5).

F5 · derivative.exercise_date: Earned restricted stock units will be settled in cash (based on the average price of the Company's common stock over the five trading days ending on the applicable vesting date) in equal quarterly installments over one year following the date the restricted stock units are earned, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.

F4 · derivative.expiration_date: The restricted stock units were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period beginning April 15, 2025 (the "Grant Date") as follows: (i) if the Company's TSR reaches 20%, 100% of the restricted stock units will be earned; (ii) if the Company's TSR reaches 40%, 200% of the restricted stock units will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 5).

F5 · derivative.expiration_date: Earned restricted stock units will be settled in cash (based on the average price of the Company's common stock over the five trading days ending on the applicable vesting date) in equal quarterly installments over one year following the date the restricted stock units are earned, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.

SEC source: 0000950170-25-055630 · ownership.xml · nonDerivative · entry 2

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,471,817

F3 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2028.

SEC source: 0000950170-25-055630 · ownership.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,483,766

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

F2 · balance_after: The total amount of securities beneficially owned following the reported transaction includes a decrease of 234,566 shares as a result of forfeitures related to previously disclosed share awards.

SEC source: 0000950170-25-053880 · ownership.xml · nonDerivative · entry 1

DAWSON G STEVEN · CIK 0001020944 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,217

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2028.

SEC source: 0000950170-25-053818 · ownership.xml · nonDerivative · entry 1

Mozingo Caterina Ardon · CIK 0001804387 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,165

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2028.

SEC source: 0000950170-25-053822 · ownership.xml · nonDerivative · entry 1

Pitman Elizabeth N · CIK 0001732148 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,595

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2028.

SEC source: 0000950170-25-053826 · ownership.xml · nonDerivative · entry 1

Murphy Emily Webster · CIK 0001914520 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,525

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2028.

SEC source: 0000950170-25-053824 · ownership.xml · nonDerivative · entry 1

Stewart Michael G · CIK 0001331453 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 245,100

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2028.

SEC source: 0000950170-25-053823 · ownership.xml · nonDerivative · entry 1

SPARKS DANIEL PAUL · CIK 0001619358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,243

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2028.

SEC source: 0000950170-25-053821 · ownership.xml · nonDerivative · entry 1

THOMPSON C REYNOLDS III · CIK 0001188038 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,492

F1 · shares: Shares vest at the beginning of each calendar quarter ending March 31, 2028.

SEC source: 0000950170-25-050797 · ownership.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,652,829

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-050798 · ownership.xml · nonDerivative · entry 1

Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 371,059

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-050802 · ownership.xml · nonDerivative · entry 1

LAMBERT CHARLES R · CIK 0001225492 · SVP of Finance and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 261,631

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-050801 · ownership.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,738,675

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-050800 · ownership.xml · nonDerivative · entry 1

Portal Larry H · CIK 0001969950 · SVP, Senior Advisor to the CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 412,013

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-050799 · ownership.xml · nonDerivative · entry 1

Hooper Rosa Handley · CIK 0001969905 · SVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 354,285

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-034778 · ownership.xml · nonDerivative · entry 1

Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 372,338

SEC source: 0000950170-25-002469 · ownership.xml · nonDerivative · entry 1

HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,664,942

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-002467 · ownership.xml · nonDerivative · entry 1

Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 364,927

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-002472 · ownership.xml · nonDerivative · entry 1

Hooper Rosa Handley · CIK 0001969905 · SVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 355,148

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-002471 · ownership.xml · nonDerivative · entry 1

Portal Larry H · CIK 0001969950 · SVP, Senior Advisor to the CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 413,584

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-002470 · ownership.xml · nonDerivative · entry 1

Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,768,871

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-25-002468 · ownership.xml · nonDerivative · entry 1

LAMBERT CHARLES R · CIK 0001225492 · SVP of Finance and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 261,886

F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.

SEC source: 0000950170-24-140621 · ownership.xml · nonDerivative · entry 1

Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 366,913

F1 · shares: The sale was made in connection with the reporting person's year-end tax planning for 2024. The reporting person intends but is not required to repurchase an equal number of shares, subject to compliance with laws and company policies, as well as then-market conditions.

SEC source: 0000950170-24-140620 · ownership.xml · nonDerivative · entry 1

Hooper Rosa Handley · CIK 0001969905 · SVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 356,600